GlassScriptPhysician profile
Nathaniel C Stocker
NPI 1679041297
$3,732.40
in general payments reported to CMS, 2019-2025
33 companies · $166 in 2025
The $166 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $787 · 2022: $784 · 2023: $1,107 · 2024: $889 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,162.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,161.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $735.98 | 2021-2024 | |
| Lilly USA, LLC | $463.95 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $330.65 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $264.04 | 2021-2024 | Dificid, Verquvo, Gardasil 9 |
| Axsome Therapeutics, INC. | $228.28 | 2022-2024 | Sunosi |
| Abbott Laboratories | $183.08 | 2023-2024 | Freestyle Libre 3, Freestyle Libre 2, Proclaim |
| Novo Nordisk INC | $173.09 | 2022-2025 | Rybelsus, Ozempic, Wegovy |
| Biohaven Pharmaceutical Holding Company LTD. | $161.21 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $154.44 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $92.85 | 2023-2024 | Xifaxan, Trulance |
| Scilex Pharmaceuticals INC. | $79.05 | 2021-2022 | |
| Exact Sciences Corporation | $75.76 | 2023-2024 | Cologuard Collection Kit |
| Esperion Therapeutics, INC. | $69.11 | 2024 | Nexletol |
| Nestle Healthcare Nutrition INC. | $63.60 | 2021-2023 | |
| Glaxosmithkline, LLC. | $61.71 | 2021-2024 | Shingrix, Arexvy, Trelegy Ellipta |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $57.57 | 2022 | |
| Phathom Pharmaceuticals, INC. | $54.45 | 2023-2024 | Voquezna |
| Biohaven Pharmaceuticals, INC. | $50.78 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $48.33 | 2024-2025 | Rexulti |
| Upsher-Smith Laboratories LLC | $43.64 | 2021 | |
| Harmony Biosciences LLC | $43.20 | 2024 | |
| Eisai INC. | $39.92 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $36.74 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.73 | 2023 | |
| Idorsia Pharmaceuticals US INC | $30.02 | 2023 | Quviviq |
| Lundbeck LLC | $26.71 | 2023 | Vyepti |
| Astellas Pharma US INC | $25.17 | 2023 | Veozah |
| Novartis Pharmaceuticals Corporation | $23.27 | 2021 | |
| Edwards Lifesciences Corporation | $20.94 | 2021 | |
| Ironwood Pharmaceuticals, INC | $18.04 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.46 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.65 | 2021 | |
| Acerus Pharmaceuticals Corporation | $11.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathaniel Stocker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.